Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F22%3A00009312" target="_blank" >RIV/00023884:_____/22:00009312 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023001:_____/22:00083368 RIV/00064203:_____/22:10448835 RIV/00216208:11110/22:10448835 RIV/00216208:11120/22:43924077 RIV/00216208:11130/22:10448835

Výsledek na webu

<a href="https://pubmed.ncbi.nlm.nih.gov/36304096/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/36304096/</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1515/tnsci-2022-0249" target="_blank" >10.1515/tnsci-2022-0249</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia

Popis výsledku v původním jazyce

Introduction ‒ Esophageal achalasia is a primary motility disorder. Although the exact pathogenesis is unknown, autoimmune, and neurodegenerative processes seem to be involved similarly to neurodegenerative and/or demyelinating disorders (NDDs). We hypothesized that the prevalence of NDDmay be higher among patients with achalasia and vice versa as the background pathogenetic mechanisms are similar. Methods ‒ This was a prospective, comparative questionnaire- based study. Patients with achalasia and patients with NDD were enrolled. Selected patients with achalasia were thoroughly examined by a neurologist and selected patients with NDD were examined by a gastroenterologist to confirm or rule out NDD or achalasia. We assessed the prevalence of both achalasia and NDD and compared them with their prevalence in general population.

Název v anglickém jazyce

Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia

Popis výsledku anglicky

Introduction ‒ Esophageal achalasia is a primary motility disorder. Although the exact pathogenesis is unknown, autoimmune, and neurodegenerative processes seem to be involved similarly to neurodegenerative and/or demyelinating disorders (NDDs). We hypothesized that the prevalence of NDDmay be higher among patients with achalasia and vice versa as the background pathogenetic mechanisms are similar. Methods ‒ This was a prospective, comparative questionnaire- based study. Patients with achalasia and patients with NDD were enrolled. Selected patients with achalasia were thoroughly examined by a neurologist and selected patients with NDD were examined by a gastroenterologist to confirm or rule out NDD or achalasia. We assessed the prevalence of both achalasia and NDD and compared them with their prevalence in general population.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Translational Neuroscience

ISSN

2081-3856

e-ISSN

—

Svazek periodika

13

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

8

Strana od-do

361-368

Kód UT WoS článku

000865543600001

EID výsledku v databázi Scopus

2-s2.0-85140650729